John Oyler $BGNE SEC Form 4 Insider Trading

John Oyler has filed a total of 234 insider trades in $BGNE since 2021. Their most recent trade was a sale of 428 shares, made on Oct 08, 2024. Their largest trade was a sale of 190,203 shares, made on Sep 15, 2021. We estimate that they now own 3.1 million shares of $BGNE, worth an estimated $569.1 million.

Insider Trading at $BGNE

There have been a total of 549 insider trades reported at $BGNE since 2021, with 165,529 shares purchased and 25.7 million shares sold. The most active insider traders in $BGNE stock have been John Oyler, Jane Huang, and Xiaobin Wu. The most recent trade was a sale of 1,301 shares reported by Xiaodong Wang (None), made on Jan 07, 2025.

$BGNE Executives and Stock Owners with Insider Trades

• John Oyler, Chief Executive Officer

• Jane Huang, CMO, Hematology

• Xiaobin Wu, President, COO & GM China

• Lai Wang, Global Head of R&D

• Julia Aijun Wang, Chief Financial Officer

• Chan Henry Lee, SVP, General Counsel

• Howard Liang, CFO & Chief Strategy Officer

• Titus B. Ball, Principal Accounting Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.